Showing results (81-90 of 92) with videos related to
Sort By:
Pageof 10
Social Psychiatry and Psychiatric Epidemiology|June 19, 2023
The relationship between genetic liability, childhood maltreatment, and IQ: findings from the EU-GEI multicentric case-control studyLucia Sideli, Monica Aas, Diego Quattrone, et al.Psychological Medicine|December 11, 2023
Cannabis use as a potential mediator between childhood adversity and first-episode psychosis: results from the EU-GEI case-control studyGiulia Trotta, Victoria Rodriguez, Diego Quattrone, et al.Molecular Psychiatry|October 15, 2024
Methylomic signature of current cannabis use in two first-episode psychosis cohortsEmma L Dempster, Chloe C Y Wong, Joe Burrage, et al.Frontiers in Pediatrics|January 9, 2023
Examining the immune signatures of SARS-CoV-2 infection in pregnancy and the impact on neurodevelopment: Protocol of the SIGNATURE longitudinal studyNathalia Garrido-Torres, Lucas Cerrillos, Susana García Cerro, et al.JAMA Psychiatry|January 12, 2022
Interaction Testing and Polygenic Risk Scoring to Estimate the Association of Common Genetic Variants With Treatment Resistance in SchizophreniaAntonio F Pardiñas, Sophie E Smart, Isabella R Willcocks, et al.Schizophrenia Bulletin Open|July 16, 2026
Relationship among Sleep Disturbance, Stress, and Suicidal Ideation in Clinical High Risk for PsychosisHeather M Wastler, Aubrey Moe, Alexandra M Blouin, et al.Schizophrenia Bulletin Open|August 27, 2025
Sample Ascertainment and Recruitment Sources in the Accelerating Medicines Partnership Schizophrenia ProgramJean Addington, Amy Shalev, Lu Liu, et al.Schizophrenia Bulletin|May 11, 2026
Premorbid adjustment problems, negative symptoms, and cognitive impairment in a large international sample at clinical high risk for psychosis: Findings from the Accelerating Medicines Partnership-SchizophreniaHenry R Cowan, Danielle Pratt, Jai L Shah, et al.Schizophrenia Bulletin Open|August 27, 2025
Baseline Clinical Characterization of Participants in the Accelerating Medicines Partnership Schizophrenia ProgramJean Addington, Lu Liu, Monica Chu, et al.Schizophrenia (Heidelberg, Germany)|April 2, 2025
The MR neuroimaging protocol for the Accelerating Medicines Partnership® Schizophrenia ProgramMichael P Harms, Kang-Ik K Cho, Alan Anticevic, et al.Pageof 10